Göran Ando, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Göran Ando, M.D.
Earlier roles on record: Board Member at Cartesian Therapeutics, Inc. (RNAC) until January 4, 2023. Cartesian Therapeutics, Inc. reported in an 8-K filed January 9, 2023 that Göran Ando, M.D. retired as member of the Board of Directors, effective January 4, 2023.
“On January 4, 2023, Göran A. Ando, M.D., a member of the Board of Directors (the “Board”) of Selecta Biosciences, Inc. (the “Company”), notified the Company that he is retiring from the Company’s Board effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-04-24–2023-01-04
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.